mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.001 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.002 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |